Tempus Raises $410M in Series Unknown

Tempus has successfully raised $410M in a Series Unknown at a $8.1B valuation led by T. Rowe Price, Franklin Templeton, Baillie Gifford.

Company Overview

Tempus is a HealthTech company headquartered in Chicago, IL, founded in 2015 with 2500+ employees.

AI-powered precision medicine and genomic testing platform

Fundraising Details

Amount Raised: $410M
Round Type: Series Unknown
Valuation: $8.1B
Date: 2025-10-16
Investors: T. Rowe Price, Franklin Templeton, Baillie Gifford

About Tempus

AI-powered precision medicine and genomic testing platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Chicago, IL
Founded: 2015
Team Size: 2500+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Tempus's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Tempus's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $8.1B valuation marks an important milestone for Tempus, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Tempus is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-10-16. For more information about Tempus, visit their headquarters at Chicago, IL.

Tempus